MedicationsMyBlueDotsStudy finds no elevated risk of thyroid cancer among GLP1-RA users MyBlueDots7 months ago01 mins A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. Go to Sourcehttps://medicalxpress.com/rss-feed/ Post navigation Previous: Survey shows previous experience affects family planning decisions of people with hereditary dementiaNext: Framework outlines steps for achieving health equity in stroke care
How noise, air pollution, heat and chemicals act together to damage the cardiovascular system MyBlueDots8 hours ago 0
Gene inhibitor found to boost immunotherapy for most aggressive form of lung cancer MyBlueDots8 hours ago 0
Children’s immune systems reveal new antibody targets for dengue vaccine development MyBlueDots8 hours ago 0